Trials / Completed
CompletedNCT01801150
CPAP in Diabetes Type 2 Patients With Sleep Apnea
Effect Of Nasal CPAP On Glycemic Control In Patients With Poorly Controlled Type 2 Diabetes And Sleep Apnea-Hypopnea Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Hospital Universitario La Paz · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Aim: To assess if six months of treatment with CPAP associated with conventional drug therapy, contribute to improved glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome SAHS)
Detailed description
Main objective: To assess the effect of 6 months of CPAP treatment associated with conventional drug therapy on glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome (SAHS)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CPAP nasal treatment | Treatment with titred CPAP nasal during the nighttime |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2014-12-01
- Completion
- 2015-01-01
- First posted
- 2013-02-28
- Last updated
- 2015-03-24
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01801150. Inclusion in this directory is not an endorsement.